This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab

Inclusion criteria -Patients are eligible to be included in the study only if all of the following criteria apply: - Patients must to be 12 years old (inclusive) at the time of signing the willing to sign a consent form. - Patients with severe eosinophilic asthma prescribed with benralizumab at the discretion of the clinician. - Blood EOS≥150/ul in the 3 months prior to or EOS≥300/ul in the 1 year prior to the time of signing the willing to sign a consent form. - Participating patients and/or their legally authorized representative must provide signed and dated written willing to sign a consent form form prior to any study specific procedures. Exclusion criteria -Patients should not enter the study if any of the following exclusion criteria are fulfilled: - Patients currently participating in any other clinical trial. - Known history of allergy or reaction to any component of the study treatment formulation. - Malignancy of any kind. - Patients with prior or ongoing treatment with benralizumab. Always talk to your doctor about whether this trial is right for you.